Book Value per Share: Omega Therapeutics (OMGA)

Graphic logo of Omega Therapeutics (OMGA)

The innovative pace of epigenomic drug development is driving asset dynamics, and the consolidated book value per share clearly demonstrates these changes. Cancer treatment projects are expanding market reach, while the implementation of eco-filtration in laboratories reduces risks. Consequently, 0.21 becomes the new value of the indicator, capturing the current equity volume of Omega Therapeutics (OMGA).

Omega (OMGA) Equity per Share: for the period 07/04/2022 - 03/08/2025

omegatherapeutics.com - analytical breakdowns and key metrics (OMGA)

- price and consensus price forecast:
Stock Price Omega|OMGA - Analyst Target Range
- market capitalization data:
Market Capitalization Omega Therapeutics, Inc.|OMGA - Enterprise Value
- book capitalization data:
Book Value per Share Omega Therapeutics|OMGA - Accounting Capitalization|Market Value to Book Value Ratio omegatherapeutics.com|OMGA - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Capital|Short-Term Debt to Equity Omega Therapeutics, Inc.|OMGA - Company Cumulative Debt|Debt to Book Capitalization Ratio Omega Therapeutics, Inc.
Fundamental company valuation:Omega - OMGA
Manufactured products of Omega Therapeutics, Inc.

The development of the OMEGA platform for epigenetic regulation and the success of clinical trials for liver cancer therapy directly determine the volume of Omega Therapeutics (OMGA) capitalized intangible assets. The book value per share reflects the portion of net assets minus debt, where prolonged periods of stagnation for this metric on the chart signal low capital accumulation dynamics and increasing risks of asset devaluation.

Competitors of Omega Therapeutics (OMGA)

Book Value per Share TEM|QGEN - Book Value of One Share|IONS: Book Value per Share|repligen.com (RGEN) - Book Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|TWST (Twist Bioscience, Inc.) - Net Assets per Single Share|TXG: Net Asset Value per Share|NTLA (Intellia) - Net Assets per Single Share|Stoke Corp (STOK) - Accounting Value per Share|Book Value per Share BLFS (BioLife Solutions, Inc.)|Net Asset Value per Share wavelifesciences.com|MAZE: Book Value per Share|Book Value of One Share Sionna Therapeutics, Inc. (SION)|Book Value per Share PRME (Prime Medicine Corp)|TSHA - Book Value per Share|Accounting Value per Share uniQure N.V. (QURE)|meiragtx.com (MGTX) - Accounting Value of a Share|RGNX - Accounting Value per Share|Solid Biosciences Inc (SLDB) - Book Price of a Share|OCGN - Book Value per Share|Accounting Value of a Share PacBio Corp|Benitec Biopharma Inc. - Book Value per Share|Net Asset Value per Share DSGN (designtx.com)|Net Assets per Single Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|Lexeo - Book Value per Share|KRRO: Book Value per Share|Net Assets per Single Share Editas Medicine, Inc. (EDIT)|silence-therapeutics.com (SLN) - Share Book Value|Book Value per Share PRQR (ProQR)|Net Asset Value per Share Codexis Bio (CDXS)|Accounting Value per Share SGMO|Book Value per Share nautilus.bio NAUT|Accounting Value per Share Metagenomi, Inc. (MGX)|Book Price of a Share Precision BioSciences Inc. DTIL|Book Value per Share GBIO (Generation Bio Corp)|BOLD - Net Assets per Share|XCUR (exicuretx.com) - Book Value per Share|IMNN (Imunon) - Accounting Value per Share|PHIO: Net Assets per Single Share|Net Assets per Share MBIO|TransCode Therapeutics - Net Assets per Single Share|Net Asset Value per Share BNGO (bionanogenomics.com)|Applied DNA - Net Assets per Single Share|Accounting Value per Share bluebird bio, Inc BLUE|Book Value per Share IPA|OMIC - Book Value of One Share|RGLS: Book Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Book Value per Share|Book Value per Share Codex DNA (TBIO)|Equity per Share TCON|Net Assets per Single Share Unity Biotechnology UBX